Treating Hearing Loss to Improve Mood and Cognition in Older Adults
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Depression
- Hearing Loss
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 60 years and 99 years
- Gender
- Both males and females
Description
This study will conduct the first clinical trial possessing these design features 40 individuals will be recruited who are aged ?60 years, diagnosed with a clinically significant depressive disorder, and have moderate ARHL with impaired speech discrimination. Comprehensive baseline psychiatric, audi...
This study will conduct the first clinical trial possessing these design features 40 individuals will be recruited who are aged ?60 years, diagnosed with a clinically significant depressive disorder, and have moderate ARHL with impaired speech discrimination. Comprehensive baseline psychiatric, audiometric, neuropsychological, and functional assessment will be performed. Participants then will be randomized to receive antidepressant medication (AD) treatment plus full amplification hearing aids or antidepressant medication plus low amplification hearing aids over a 12-week prospective trial. Data from this study could suggest a novel therapeutic strategy for LLD and thereby mitigate its public health burden, while also contributing to the increased recognition and treatment of ARHL more generally.
Tracking Information
- NCT #
- NCT03321006
- Collaborators
- National Institute on Aging (NIA)
- Investigators
- Principal Investigator: Bret Rutherford, MD New York State Psychiatric Institute
Get Well Soon